VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ELCC 2021 | CAR-T therapy for lung cancer

Adam Schoenfeld, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the need for improved therapies for patients with lung cancer and the potential role of chimeric antigen receptor T-cell (CAR-T) therapy, which has shown promising results in hematological malignancies. Dr Schoenfeld also highlights challenges of CAR-T therapy which are unique to solid tumors. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.

Disclosures

None

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter